Stock Research for OPK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

OPK Stock Chart & Research Data

The OPK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OPK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


OPK Due diligence Resources & Stock Charts

The OPK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OPK Detailed Price Forecast - CNN Money CNN View OPK Detailed Summary - Google Finance
Yahoo View OPK Detailed Summary - Yahoo! Finance Zacks View OPK Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View OPK Trends & Analysis - Trade-Ideas Barrons View OPK Major Holders - Barrons
NASDAQ View OPK Call Transcripts - NASDAQ Seeking View OPK Breaking News & Analysis - Seeking Alpha
Spotlight View OPK Annual Report - CompanySpotlight.com OTC Report View OPK OTC Short Report - OTCShortReport.com
TradeKing View OPK Fundamentals - TradeKing Charts View OPK SEC Filings - Bar Chart
WSJ View Historical Prices for OPK - The WSJ Morningstar View Performance/Total Return for OPK - Morningstar
MarketWatch View the Analyst Estimates for OPK - MarketWatch CNBC View the Earnings History for OPK - CNBC
StockMarketWatch View the OPK Earnings - StockMarketWatch MacroAxis View OPK Buy or Sell Recommendations - MacroAxis
Bullish View the OPK Bullish Patterns - American Bulls Short Pains View OPK Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View OPK Stock Mentions - StockTwits PennyStocks View OPK Stock Mentions - PennyStockTweets
Twitter View OPK Stock Mentions - Twitter Invest Hub View OPK Investment Forum News - Investor Hub
Yahoo View OPK Stock Mentions - Yahoo! Message Board Seeking Alpha View OPK Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for OPK - SECform4.com Insider Cow View Insider Transactions for OPK - Insider Cow
CNBC View OPK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OPK - OTC Markets
Yahoo View Insider Transactions for OPK - Yahoo! Finance NASDAQ View Institutional Holdings for OPK - NASDAQ


Stock Charts

FinViz View OPK Stock Insight & Charts - FinViz.com StockCharts View OPK Investment Charts - StockCharts.com
BarChart View OPK Stock Overview & Charts - BarChart Trading View View OPK User Generated Charts - Trading View


Latest Financial News for OPK

GeneDx Announces Completion of 100,000 Exome Sequences
Posted on Tuesday June 12, 2018

Exome sequencing is a process by which the protein-coding genes in the human genome are sequenced.  It is used to help diagnose disease by identifying variations in these genes that may lead to a variety of neurological, metabolic or other disorders. Over the past three years, GeneDx has helped discover and publish more than 62 disease-causing genes, thereby contributing to the phenotypic, or observable characteristics, involved in identifying and further understanding developmental delay and intellectual disability.  GeneDx has grown in exome volume by a compound annual growth rate of 55% since its inception.  With over 100 professionals dedicated to exomes and genomes, including MDs, PhDs and genetic counselors, GeneDx has developed a suite of patient-focused exome and genome tests for a variety of clinical indications and scenarios, including family-based testing, rapid testing for critically ill patients, prenatal testing and exome testing in parallel with mitochondrial genetic testing.


Today's Research Reports on Trending Tickers: Valeant Pharmaceuticals and OPKO Health
Posted on Monday June 11, 2018

NEW YORK, NY / ACCESSWIRE / June 11, 2018 / U.S. markets finished higher and logged strongest week in months as investors shrug off tensions between U.S. and its allies. The Dow Jones Industrial Average ...


OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
Posted on Monday June 11, 2018

Based on preclinical and Phase 2 data, the use of the dual agonist, OPK88003, once-weekly with an optimized dosing regimen, could more effectively improve glucose control, increase weight loss and improve the lipid profile in type 2 diabetics compared with the currently available GLP-1 medicines.


Why OPKO Health, Inc. Stock Rocketed Higher in May
Posted on Saturday June 09, 2018

Opko's shares benefited from a better-than-expected first-quarter earnings release last month, but the company's good fortunes didn't last long.


Enter a stock symbol to view the stock details.